Cargando…

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab

Ghrelin is a gastric hormone that posses multiple functions, including induction of growth hormone release, regulation of proinflammatory cytokines and control of food intake and energy homeostasis. A few reports on serum ghrelin level in chronic inflammatory states revealed contradictory results. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magiera, Michal, Kopec-Medrek, Magdalena, Widuchowska, Małgorzata, Kotulska, Anna, Dziewit, Tomasz, Ziaja, Damian, Kucharz, Eugene J., Logiewa-Bazger, Beata, Mazur, Wlodzimierz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663990/ https://www.ncbi.nlm.nih.gov/pubmed/22198659 http://dx.doi.org/10.1007/s00296-011-2262-7

Ejemplares similares

Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist
por: Kopec-Medrek, Magdalena, et al.
Publicado: (2011)

Opinion of patients with ankylosing spondylitis on risk factors impairing their quality of life
por: Kucharz, Eugene J., et al.
Publicado: (2012)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases
por: Kotulska, Anna, et al.
Publicado: (2015)

Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors
por: Szeremeta, Anna, et al.
Publicado: (2020)

Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
por: Szeremeta, Anna, et al.
Publicado: (2018)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management
por: Kucharz, Eugeniusz J., et al.
Publicado: (2019)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis
por: Lis-Święty, Anna, et al.
Publicado: (2018)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

How does infliximab work in rheumatoid arthritis?
por: Maini, Ravinder N, et al.
Publicado: (2002)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Ghrelin plasma levels, gastric ghrelin cell density and bone mineral density in women with rheumatoid arthritis
por: Maksud, F.A.N., et al.
Publicado: (2017)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
por: Dwivedi, Ravi C, et al.
Publicado: (2009)

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
por: Gieszczyk-Strózik, Klaudia, et al.
Publicado: (2021)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
por: Bobbio-Pallavicini, Francesca, et al.
Publicado: (2004)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
por: Lequerré, Thierry, et al.
Publicado: (2006)

An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis
por: Julià, Antonio, et al.
Publicado: (2009)

Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
por: Konopelko, OU, et al.
Publicado: (2011)

Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
por: Di Micco, Pierpaolo, et al.
Publicado: (2009)

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
por: Delabaye, Isabelle, et al.
Publicado: (2010)

Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients
por: Korczowska, Izabela, et al.
Publicado: (2013)

Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report
por: Carvalho, Clarissa Luiza Dalla Bernardina, et al.
Publicado: (2014)

Ramsay Hunt Syndrome in a Patient with Rheumatoid Arthritis after Treatment with Infliximab
por: Nagayama, Yoshio, et al.
Publicado: (2014)

Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis
por: Kanbe, Katsuaki, et al.
Publicado: (2015)

The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
por: Bray, Vance J., et al.
Publicado: (2018)

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
por: Lu, Yun-Chi, et al.
Publicado: (2019)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy
por: Rodríguez-Prieto, Tamara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e00i0qbut057uv28eub9asenf8